CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BBIO — BridgeBio Pharma, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in BBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$127,317,377
-$19,427,363 QoQ
Shares Held
1,709,417
-13.5% QoQ
Ownership
0.874%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#27
of 472 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. BBIO ranks #11 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in BBIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,317,377 | 1,709,417 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $146,744,740 | 1,976,094 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $150,258,409 | 1,964,419 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $99,994,784 | 1,925,198 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $57,493,004 | 1,331,473 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $44,326,656 | 1,282,229 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $35,857,631 | 1,306,765 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $32,711,058 | 1,284,802 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $30,122,360 | 1,189,197 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $32,405,304 | 1,048,037 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $45,344,391 | 1,123,220 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $27,853,971 | 1,056,275 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $16,562,757 | 962,951 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $15,333,548 | 924,822 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,066,426 | 796,119 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,670,260 | 771,656 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,717,043 | 1,070,159 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,952,682 | 1,079,082 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,435,437 | 1,045,290 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $49,095,950 | 1,047,492 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $44,322,918 | 727,082 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $42,475,171 | 689,532 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $37,577,581 | 528,443 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $19,605,813 | 522,543 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,426,782 | 258,411 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $7,386,822 | 254,718 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||